Stanford Scientists Regrow Knee Cartilage by Blocking 15-PGDH in Arthritis Breakthrough
Updated
Updated · My Modern Met · May 26
Stanford Scientists Regrow Knee Cartilage by Blocking 15-PGDH in Arthritis Breakthrough
3 articles · Updated · My Modern Met · May 26
Stanford researchers restored aging knee cartilage by injecting a small-molecule blocker of 15-PGDH, reversing cartilage loss in old mice and improving their muscle mass and endurance.
Human knee tissue from replacement surgeries also generated new functional cartilage after the treatment, suggesting the approach could target the underlying cause of osteoarthritis rather than just symptoms.
The same inhibitor prevented arthritis from developing after knee injuries such as ACL tears, widening its potential use beyond age-related joint degeneration.
About 53 million U.S. adults have arthritis, and researchers said no approved drug directly treats cartilage loss; an oral version of the therapy is already in clinical trials for age-related muscle weakness.
If a pill can truly reverse aging in joints, what part of the human body is next?
What long-term health risks could arise from blocking a fundamental aging enzyme to regrow cartilage?
With human trials now active, could this breakthrough make knee surgery obsolete by 2030?
15-PGDH Inhibitors for Cartilage Regeneration: Stanford’s Breakthrough and the Road to Clinical Application
Overview
Stanford University’s research on the 15-PGDH inhibitor is making strong progress toward clinical use for cartilage regeneration. Laboratory studies show that human knee tissue responds well to this treatment, which could become a simple injection or oral medication. This approach has the potential to restore lost cartilage and may reduce the need for joint replacement surgeries for millions of people. The next step is to start clinical trials focused on cartilage repair, and previous trials for similar drugs have shown a good safety profile, which could help speed up the process toward making this therapy available to patients.